Regulation of corticoid and serotonin receptor brain system following early life exposure of glucocorticoids: Long term implications for the neurobiology of mood

Psychoneuroendocrinology

Volumn 37, Issue 3, 2012, Pages 421-437

  Vázquez, Delia M ^a   Neal, Charles R ^c   Patel, Paresh D ^a,b   Kaciroti, Niko ^a   López, Juan F ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

Adult; Animals; Anxiety Behavior Attention; Body weight drug effects; Dexamethasone administration dosage adverse effects; Hydrocortisone administration dosage adverse effects; Newborn growth development; Rat; Stress response

Indexed keywords

CORTICOSTEROID RECEPTOR; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GENE EXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIGHT DARK CYCLE; MALE; MICRODENSITOMETRY; MOOD; NEUROBIOLOGY; NEWBORN PERIOD; NONHUMAN; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STRESS;

AFFECT; ANIMALS; ANIMALS, NEWBORN; ANXIETY; BODY WEIGHT; BRAIN; CORTICOSTERONE; DEXAMETHASONE; EATING; GLUCOCORTICOIDS; HOUSING, ANIMAL; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RECEPTORS, SEROTONIN; SEROTONERGIC NEURONS; STRESS, PSYCHOLOGICAL;

EID: 84856574735     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.07.012     Document Type: Article

References (125)

1. Ader R., Beels C.C., Tatum R. Social factors affecting emotinality and resistance to disease in animals: II. Susceptibility to gastric ulceration as a function of interruptions in social interactions and the time at which they occur. J. Comp. Physiol. Psychol. 1960, 53:455-458.
2. American Academy of Pediatrics T.F. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002, 109(2):330-338.
3. Ansorge M.S., Zhou M., Lira A., Hen R., Gingrich J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004, 306:879-881.
4. Ballard P.L., Gluckman P.D., Liggins G.C., Kaplan S.L., Grumbach M.M. Steroid and growth hormone levels in premature infants after prenatal betamethasone therapy to prevent respiratory distress syndrome. Pediatr. Res. 1980, 14(2):122-127.
5. Barrington K.J. Postnatal steroids and neurodevelopmental outcomes: a problem in the making. Pediatrics 2001, 107(6):1425-1426.
6. Benders M.J., Groenendaal F., van Bel F., Ha Vinh R., Dubois J., Lazeyras F., Warfield S.K., Huppi P.S., de Vries L.S. Brain development of the preterm neonate after neonatal hydrocortisone treatment for chronic lung disease. Pediatr. Res. 2009.
7. Benesova O., Pavlik A. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain. Neuropharmacology 1989, 28(1):89-97.
8. Bhatt-Mehta, V., Huang, L.S., Neal, C.R., Pawar, M., Vazquez, D.M. Tapering dose of hydrocortisone and dexamethasone in neonatal rats: effect on the growth, neurological development and hypothalamic-pituitary-adrenal response to stress at pre-adolescence. Stress, submitted.
9. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 1994, 15(7):220-226.
10. Botting N., Powls A., Cooke R.W., Marlow N. Attention deficit hyperactivity disorders and other psychiatric outcomes in very low birthweight children at 12 years. J. Child Psychol. Psychiatry 1997, 38(8):931-941.
11. Bourin M., Hascoet M. The mouse light/dark box test. Eur. J. Pharmacol. 2003, 463(1-3):55-65.
12. Brunelli S.A., Shair H.N., Hofer M.A. Hypothermic vocalizations of rat pups (Rattus norvegicus) elicit and direct maternal search behavior. J. Comp. Psychol. 1994, 108(3):298-303.
13. Casolini P., Domenici M.R., Cinque C., Alema G.S., Chiodi V., Galluzzo M., Musumeci M., Mairesse J., Zuena A.R., Matteucci P., Marano G., Maccari S., Nicoletti F., Catalani A. Maternal exposure to low levels of corticosterone during lactation protects the adult offspring against ischemic brain damage. J. Neurosci. 2007, 27(26):7041-7046.
14. Catalani A., Marinelli M., Scaccianoce S., Nicolai R., Muscolo L.A., Porcu A., Koranyi L., Piazza P.V., Angelucci L. Progeny of mothers drinking corticosterone during lactation has lower stress-induced corticosterone secretion and better cognitive performance. Brain Res. 1993, 624(1-2):209-215.
15. Centers for Disease Control and Prevention QuickStats: distribution of births, by gestational age-United States. MMWR 2007, 14:344.
16. Cirulli F., Berry A., Bonsignore L.T., Capone F., D'Andrea I., Aloe L., Branchi I., Alleva E. Early life influences on emotional reactivity: evidence that social enrichment has greater effects than handling on anxiety-like behaviors, neuroendocrine responses to stress and central BDNF levels. Neurosci. Biobehav. Rev. 2010, 34(6):808-820.
17. Crochemore C., Lu J., Wu Y., Liposits Z., Sousa N., Holsboer F., Almeida O.F. Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol. Psychiatry 2005, 10(8):790-798.
18. Cummings J.J., D'Eugenio D.B., Gross S.J. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N. Engl. J. Med. 1989, 320(23):1505-1510.
19. Davis E.P., Townsend E.L., Gunnar M.R., Georgieff M.K., Guiang S.F., Ciffuentes R.F., Lussky R.C. Effects of prenatal betamethasone exposure on regulation of stress physiology in healthy premature infants. Psychoneuroendocrinology 2004, 29(8):1028-1036.
20. De Kloet E.R., Rosenfeld P., Van Eekelen J.A., Sutanto W., Levine S. Stress, glucocorticoids and development. Prog Brain Res 1988, 73:101-120.
21. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 1998, 19(3):269-301.
22. Dellu F., Piazza P.V., Mayo W., Le Moal M., Simon H. Novelty-seeking in rats-biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology 1996, 34(3):136-145.
23. Dobbing J. The Later Development of the Brain and its Vulnerability 1974, Heinemann Medical Books, London.
24. Dobbing J. The Later Development of the Brain and its Vulnerability 1981, Heinemann Medical Books, London.
25. Dorr H.G., Heller A., Versmold H.T., Sippell W.G., Herrmann M., Bidlingmaier F., Knorr D. Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy. J. Clin. Endocrinol. Metab. 1989, 68(5):863-868.
26. Doyle L., Davis P. Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function. J. Paediatr. Child Health 2000, 36(2):101-107.
27. Dupont J., LeRoith D. Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm. Res. 2001, 55(Suppl. 2):22-26.
28. Eriksson J.G., Forsen T., Tuomilehto J., Osmond C., Barker D.J. Early adiposity rebound in childhood and risk of Type 2 diabetes in adult life. Diabetologia 2003, 46(2):190-194.
29. Felszeghy K., Bagdy G., Nyakas C. Blunted pituitary-adrenocortical stress response in adult rats following neonatal dexamethasone treatment. J. Neuroendocrinol. 2000, 12(10):1014-1021.
30. Felszeghy K., Gaspar E., Nyakas C. Long-term selective down-regulation of brain glucocorticoid receptors after neonatal dexamethasone treatment in rats. J. Neuroendocrinol. 1996, 8(7):493-499.
31. Ferguson S.A., Holson R.R. Neonatal dexamethasone on day 7 causes mild hyperactivity and cerebellar stunting. Neurotoxicol. Teratol. 1999, 21(1):71-76.
32. File S.E. New strategies in the search for anxiolytics. Drug Des. Deliv. 1990, 5(3):195-201.
33. Fischer A.K., von Rosenstiel P., Fuchs E., Goula D., Almeida O.F., Czeh B. The prototypic mineralocorticoid receptor agonist aldosterone influences neurogenesis in the dentate gyrus of the adrenalectomized rat. Brain Res. 2002, 947(2):290-293.
34. Flagel S.B., Neal J.C.R., Watson J.S.J., Vázquez D.M. Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R55-R63.
35. Flagel S.B., Vazquez D.M., Watson S.J., Neal C.R. Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282(1):R55-R63.
36. Gaillard P.J., Voorwinden L.H., Nielsen J.L., Ivanov A., Atsumi R., Engman H., Ringbom C., de Boer A.G., Breimer D.D. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur. J. Pharm. Sci. 2001, 12(3):215-222.
37. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 2002, 4(12):1002-1012.
38. Gould E. The effects of adrenal steroids and excitatory input on neuronal birth and survival. Ann. N. Y. Acad. Sci. 1994, 743:73-92. discussion 92-93.
39. Grino M. Prenatal nutritional programming of central obesity and the metabolic syndrome: role of adipose tissue glucocorticoid metabolism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289(5):R1233-R1235.
40. Gunnar M., Vázquez D.M. Stress neurobiology and developmental psychopathology. Developmental Neuroscience 2006, vol. 2:533-577. Wiley, New York.
41. Hack M., Fanaroff A.A. Outcomes of children of extremely low birthweight and gestational age in the 1990s. Early Hum. Dev. 1999, 53(3):193-218.
42. Hack M., Wilson-Costello D., Friedman H., Taylor G.H., Schluchter M., Fanaroff A.A. Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000g: 1992-1995. Arch. Pediatr. Adolesc. Med. 2000, 154(7):725-731.
43. Hagberg H., Bona E., Gilland E., Puka-Sundvall M. Hypoxia-ischaemia model in the 7-day-old rat: possibilities and shortcomings. Acta Paediatr. 1997, (Suppl. 422):85-88.
44. Halliday H.L., Ehrenkranz R.A., Doyle L.W. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst. Rev. 2003, (1):CD001144.
45. Hatch A.M., Wiberg G.S., Zawidzka Z., Cann M., Airth J.M., Grice H.C. Isolation syndrome in the rat. Toxicol. Appl. Pharmacol. 1965, 7(5):737-745.
46. Heine V.M., Rowitch D.H. Hedgehog signaling has a protective effect in glucocorticoid-induced mouse neonatal brain injury through an 11betaHSD2-dependent mechanism. J. Clin. Invest. 2009, 119(2):267-277.
47. Herman J.P., Patel P.D., Akil H., Watson S.J. Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol. Endocrinol. 1989, 3(11):1886-1894.
48. Hille E.T., den Ouden A.L., Saigal S., Wolke D., Lambert M., Whitaker A., Pinto-Martin J.A., Hoult L., Meyer R., Feldman J.F., Verloove-Vanhorick S.P., Paneth N. Behavioural problems in children who weigh 1000g or less at birth in four countries. Lancet 2001, 357(9269):1641-1643.
49. Holson R.R., Scallet A.C., Ali S.F., Turner B.B. " Isolation stress" revisited: isolation-rearing effects depend on animal care methods. Physiol. Behav. 1991, 49(6):1107-1118.
50. Johnson E.O., Kamilaris T.C., Calogero A.E., Gold P.W., Chrousos G.P. Effects of early parenting on growth and development in a small primate. Pediatr. Res. 1996, 39(6):999-1005.
51. Kabbaj M., Devine D.P., Savage V.R., Akil H. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J. Neurosci. 2000, 20(18):6983-6988.
52. Kalabis G.M., Kostaki A., Andrews M.H., Petropoulos S., Gibb W., Matthews S.G. Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection. Biol. Reprod. 2005, 73(4):591-597.
53. Kalabis G.M., Petropoulos S., Gibb W., Matthews S.G. Multidrug resistance phosphoglycoprotein (ABCB1) expression in the guinea pig placenta: developmental changes and regulation by betamethasone. Can. J. Physiol. Pharmacol. 2009, 87(11):973-978.
54. Kanagawa T., Tomimatsu T., Hayashi S., Shioji M., Fukuda H., Shimoya K., Murata Y. The effects of repeated corticosteroid administration on the neurogenesis in the neonatal rat. Am. J. Obstet. Gynecol. 2006, 194(1):231-238.
55. Karemaker R., Kavelaars A., ter Wolbeek M., Tersteeg-Kamperman M., Baerts W., Veen S., Samsom J.F., Visser G.H., van Bel F., Heijnen C.J. Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age. Pediatrics 2008, 121(4):e870-e878.
56. Kauffman K.S., Seidler F.J., Slotkin T.A. Prenatal dexamethasone exposure causes loss of neonatal hypoxia tolerance: cellular mechanisms. Pediatr. Res. 1994, 35(5):515-522.
57. Kauppila A., Tuimala R., Ylikorkala O., Haapalahti J., Karppanen H., Viinikka L. Effects of ritodrine and isoxsuprine with and without dexamethasone during late pregnancy. Obstet. Gynecol. 1978, 51(3):288-292.
58. Kino T. Tissue glucocorticoid sensitivity: beyond stochastic regulation on the diverse actions of glucocorticoids. Horm. Metab. Res. 2007, 39(6):420-424.
59. Kino T., De Martino M.U., Charmandari E., Mirani M., Chrousos G.P. Tissue glucocorticoid resistance/hypersensitivity syndromes. J. Steroid Biochem. Mol. Biol. 2003, 85(2-5):457-467.
60. Kreider M.L., Tate C.A., Cousins M.M., Oliver C.A., Seidler F.J., Slotkin T.A. Lasting effects of developmental dexamethasone treatment on neural cell number and size, synaptic activity, and cell signaling: critical periods of vulnerability, dose-effect relationships, regional targets, and sex selectivity. Neuropsychopharmacology 2006, 31(1):12-35.
61. Kurosawa A., Kageyama H., John T.M., Hirota R., Itoh S. Effect of neonatal hydrocortisone treatment on brain monoamines in developing rats. Jpn. J. Pharmacol. 1980, 30(2):213-220.
62. Langley-Evans S.C. Developmental programming of health and disease. Proc. Nutr. Soc. 2006, 65(1):97-105.
63. Lauder J.M. Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal. Ann. N. Y. Acad. Sci. 1990, 600:297-313. Discussion 314.
64. Leret M.L., Peinado V., Suarez L.M., Tecedor L., Gamallo A., Gonzalez J.C. Role of maternal adrenal glands on the developing serotoninergic and aminoacidergic systems of the postnatal rat brain. Int. J. Dev. Neurosci. 2004, 22(2):87-93.
65. Levine S. The ontogeny of the hypothalamic-pituitary-adrenal axis. The influence of maternal factors. Ann. N. Y. Acad. Sci. 1994, 746:275-288. Discussion 289-293.
66. Lodygensky G.A., Rademaker K., Zimine S., Gex-Fabry M., Lieftink A.F., Lazeyras F., Groenendaal F., de Vries L.S., Huppi P.S. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Pediatrics 2005, 116(1):1-7.
67. Lorenz J.M. The outcome of extreme prematurity. Semin. Perinatol. 2001, 25(5):348-359.
68. Lynch A. Postnatal undernutrition: an alternative method. Dev. Psychobiol. 1976, 9(1):39-48.
69. Macleod M.R., Johansson I.M., Soderstrom I., Lai M., Gido G., Wieloch T., Seckl J.R., Olsson T. Mineralocorticoid receptor expression and increased survival following neuronal injury. Eur. J. Neurosci. 2003, 17(8):1549-1555.
70. Macri S., Granstrem O., Shumilina M., Antunes Gomes dos Santos F.J., Berry A., Saso L., Laviola G. Resilience and vulnerability are dose-dependently related to neonatal stressors in mice. Horm. Behav. 2009, 56(4):391-398.
71. Mann J.J., Huang Y.Y., Underwood M.D., Kassir S.A., Oppenheim S., Kelly T.M., Dwork A.J., Arango V. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch. Gen. Psychiatry 2000, 57(8):729-738.
72. Martens S.E., Rijken M., Stoelhorst G.M., van Zwieten P.H., Zwinderman A.H., Wit J.M., Hadders-Algra M., Veen S. Is hypotension a major risk factor for neurological morbidity at term age in very preterm infants?. Early Hum. Dev. 2003, 75(1-2):79-89.
73. Matthews S.G. Early programming of the hypothalamo-pituitary-adrenal axis. Trends Endocrinol. Metabol. 2002, 13(9):373-380.
74. McCullers D.L., Herman J.P. Mineralocorticoid receptors regulate bcl-2 and p53 mRNA expression in hippocampus. Neuroreport 1998, 9(13):3085-3089.
75. McEwen B., Brinton R., Harrelson A., Rostene W. Modulatory interactions between steroid hormones, neurotransmitters and neuropeptides in hippocampus. Adv. Biochem. Psychopharmacol. 1987, 43:87-102.
76. McEwen B., Chao H., Spencer R., Brinton R., Macisaac L., Harrelson A. Corticosteroid receptors in brain: relationship of receptors to effects in stress and aging. Ann. N. Y. Acad. Sci. 1987, 512:394-401.
77. McEwen B.S. Glucocorticoid-biogenic amine interactions in relation to mood and behavior. Biochem. Pharmacol. 1987, 36(11):1755-1763.
78. McEwen B.S. Corticosteroids and hippocampal plasticity. Ann. N. Y. Acad. Sci. 1994, 746(134-42):178-179. Discussion 142-144.
79. McEwen B.S. Effects of adverse experiences for brain structure and function. Biol. Psychiatry 2000, 48(8):721-731.
80. Meaney M.J. Epigenetics and the biological definition of gene×environment interactions. Child Dev. 2010, 81(1):41-79.
81. Neal C.R.J., VanderBeek B.L., Vázquez D.M., Watson S.J.J.I.P.A. Dexamethasone exposure during the neonatal period alters ORL1 mRNA expression in the hypothalamic paraventricular nucleus and hippocampus of the adult rat. Developmental Brain Research 2004, 146:15-24.
82. Neal C.R.J., Weidemann G., Kabbaj M., Vázquez D.M. Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R375-R385.
83. Ng P.C., Lam C.W., Lee C.H., Chan I.H., Wong S.P., Fok T.F., Lam C.W.K., Chan I.H.S., Wong S.P.S. Suppression and recovery of the hypothalamic function after high-dose corticosteroid treatment in preterm infants. Neonatology 2008, 94(3):170-175.
84. O'Shea T.M., Kothadia J.M., Klinepeter K.L., Goldstein D.J., Jackson B.G., Weaver R.G., Dillard R.G. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics 1999, 104(1 Pt 1):15-21.
85. Oitzl M.S., Champagne D.L., van der Veen R., de Kloet E.R. Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci. Biobehav. Rev. 2010, 34(6):853-866.
86. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic, Orlando, FL.
87. Peltoniemi O.M., Lano A., Puosi R., Yliherva A., Bonsante F., Kari M.A., Hallman M., Neonatal Hydrocortisone Working Group Trial of early neonatal hydrocortisone: two-year follow-up. Neonatology 2009, 95(3):240-247.
88. Petropoulos S., Kalabis G.M., Gibb W., Matthews S.G. Functional changes of mouse placental multidrug resistance phosphoglycoprotein (ABCB1) with advancing gestation and regulation by progesterone. Reprod. Sci. 2007, 14(4):321-328.
89. Pharoah P.O., Stevenson C.J., Cooke R.W., Stevenson R.C. Prevalence of behaviour disorders in low birthweight infants. Arch. Dis. Child. 1994, 70(4):271-274.
90. Pivonello R., De Leo M., Vitale P., Cozzolino A., Simeoli M.C., Lombardi G., Colao A. Pathophysiology of diabetes mellitus in Cushing's syndrome. Neuroendocrinology 2010, 92(Suppl. 1):77-81.
91. Ramos A. Animal models of anxiety: do I need multiple tests?. Trends Pharmacol. Sci. 2008, 29(10):493-498.
92. Saigal S. Follow-up of very low birthweight bavies to adolescence. Semin. Neonatol. 2000, 5:107-118.
93. Sajaniemi N., Hakamies-Blomqvist L., Makela J., Avellan A., Rita H., von Wendt L. Cognitive development, temperament and behavior at 2 years as indicative of language development at 4 years in pre-term infants. Child Psychiatry Hum. Dev. 2001, 31(4):329-346.
94. Schanberg S.M., Evoniuk G., Kuhn C.M. Tactile and nutritional aspects of maternal care: specific regulators of neuroendocrine function and cellular development. Proc. Soc. Exp. Biol. Med. 1984, 175(2):135-146.
95. Schinkel A.H., Wagenaar E., van Deemter L., Mol C.A., Borst P. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 1995, 96(4):1698-1705.
96. Schmidt M.V. Molecular mechanisms of early life stress-lessons from mouse models. Neurosci. Biobehav. Rev. 2010, 34(6):845-852.
97. Schothorst P.F., van Engeland H. Long-term behavioral sequelae of prematurity. J. Am. Acad. Child Adolesc. Psychiatry 1996, 35(2):175-183.
98. Seckl J.R. Glucocorticoids, developmental 'programming' and the risk of affective dysfunction. Prog. Brain Res. 2008, 167:17-34.
99. Slotkin T.A., Barnes G., Lau C., Seidler F.J., Seidler F.J., Trepanier P., Weigel S.J., Whitmore W.L. Development of polyamine and biogenic amine systems in brains and hearts of neonatal rats given dexamethasone: role of biochemical alterations in cellular maturation for producing deficits in ontogeny of neurotransmitter levels, uptake, storage and turnover. J. Pharmacol. Exp. Ther. 1982, 221(3):686-693.
100. Slotkin T.A., Kreider M.L., Tate C.A., Seidler F.J. Critical prenatal and postnatal periods for persistent effects of dexamethasone on serotonergic and dopaminergic systems. Neuropsychopharmacology 2006, 31(5):904-911.
101. Smythe J.W., Murphy D., Timothy C., Costall B. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats. Pharmacol. Biochem. Behav. 1997, 56(3):507-513.
102. Spencer R.L., Kim P.J., Kalman B.A., Cole M.A. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Endocrinology 1998, 139(6):2718-2726.
103. Stern J.A., Winokur G., Eisenstein A., Taylor R., Sly M. The effect of group vs. individual housing on behaviour and physiological responses to stress in the albino rat. J. Psychosom. Res. 1960, 4:185-190.
104. Stern J.M. Offspring-induced nurturance: animal-human parallels. Dev. Psychobiol. 1997, 31(1):19-37.
105. Stjernqvist K., Svenningsen N.W. Extremely low-birth-weight infants less than 901g: development and behaviour after 4 years of life. Acta Paediatr. 1995, 84(5):500-506.
106. Stoelhorst G.M., Martens S.E., Rijken M., van Zwieten P.H., Zwinderman A.H., Wit J.M., Veen S. Behaviour at 2 years of age in very preterm infants (gestational age <32 weeks). Acta Paediatr. 2003, 92(5):595-601.
107. Stoelhorst G.M., Rijken M., Martens S.E., van Zwieten P.H., Feenstra J., Zwinderman A.H., Wit J.M., Veen S., Leiden P. Follow-up project on developmental outcome at 18 and 24 months of age in very preterm children: a cohort study from 1996 to 1997. Early Hum. Dev. 2003, 72(2):83-95.
108. Sullivan R.M., Holman P.J. Transitions in sensitive period attachment learning in infancy: the role of corticosterone. Neurosci. Biobehav. Rev. 2010, 34(6):835-844.
109. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., Willingham M.C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. U.S.A. 1987, 84(21):7735-7738.
110. Thompson D.K., Wood S.J., Doyle L.W., Warfield S.K., Lodygensky G.A., Anderson P.J., Egan G.F., Inder T.E. Neonate hippocampal volumes: prematurity, perinatal predictors, and 2-year outcome. Ann. Neurol. 2008, 63(5):642-651.
111. Uhr M., Holsboer F., Muller M.B. Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J. Neuroendocrinol. 2002, 14(9):753-759.
112. van der Heide-Jalving M., Kamphuis P.J., van der Laan M.J., Bakker J.M., Wiegant V.M., Heijnen C.J., Veen S., van Bel F. Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone?. Acta Paediatr. 2003, 92(7):827-835.
113. Vazquez D.M. Stress and the developing limbic-hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 1998, 23(7):663-700.
114. Vázquez D.M., López J.F., Morano M.I., Akil H. Short-term adrenalectomy increases glucocorticoid and mineralocorticoid receptor mRNA in selective areas of the developing hippocampus. Mol. Cell. Neurosci. 1993, 4:455-471.
115. Walker C.D., Anand K.J.S., Plotsky P.M. Development of the hypothalamic-pituitary-adrenal axis and the stress response. Coping with the Environment 2001, Oxford University Press, New York. B.S. McEwen (Ed.).
116. Watterberg K.L., Gerdes J.S., Cook K.L. Impaired glucocorticoid synthesis in premature infants developing chronic lung disease. Pediatr. Res. 2001, 50(2):190-195.
117. Weiler H.A, Wang Z., Atkinson S.A. Whole body lean mass is altered by dexamethasone treatment through reductions in protein and energy utilization in piglets. Biol. Neonate 1997, 71(1):53-59.
118. Weinstock M., Matlina E., Maor G.I., Rosen H., McEwen B.S. Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat. Brain Res. 1992, 595(2):195-200.
119. Whitelaw A., Thoresen M. Antenatal steroids and the developing brain. Arch. Dis. Child. Fetal Neonatal Ed. 2000, 83(2):F154-F157.
120. Wiener S.G., Fitzpatrick K.M., Levin R., Smotherman W.P., Levine S. Alterations in the maternal behavior of rats rearing malnourished offspring. Dev. Psychobiol. 1977, 10(3):243-254.
121. Wiener S.G., Levine S. Perinatal malnutrition and early handling: interactive effects on the development of the pituitary-adrenal system. Dev. Psychobiol. 1978, 11(4):335-352.
122. Wittekind C.A., Arnold J.D., Leslie G.I., Luttrell B., Jones M.P. Longitudinal study of plasma ACTH and cortisol in very low birth weight infants in the first 8 weeks of life. Early Hum. Dev. 1993, 33(3):191-200.
123. Zennaro M.C., Caprio M., Feve B. Mineralocorticoid receptors in the metabolic syndrome. Trends Endocrinol. Metab. 2009, 20(9):444-451.
124. Zhang H.F., Wang W.P., Yang Y., Zhang Y.L., Pi Y.L., Tian X.Y., Jiang X.F. Dexamethasone up-regulates the expression of glucocorticoid receptor in growth plate and inhibits the longitudinal growth of bone: experiment with rats. Zhonghua Yi Xue Za Zhi 2007, 87(36):2575-2577.
125. Zhuang X., Gross C., Santarelli L., Compan V., Trillat A.C., Hen R. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology 1999, 21(2 Suppl):52S-60S.